Scientific Conference R13

科学会议 R13

• 批准号: 8495190
• 负责人: BALWANT Singh AHLUWALIA
• 金额: $ 0.1万
• 依托单位: HOWARD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-22 至 2013-09-21
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8495190
• 关键词: Accreditation; Address; African American; Area; Basic Science; Categories; Characteristics; Clinical; Clinical Research; Clinical Sciences; Collaborations; Communication; Communities; Community Physician; Data; Diagnostic; Education; Educational Activities; Epidemiology; Evidence based treatment; Extramural Activities; Eye; Female; Fibroid Tumor; Fostering; Functional disorder; Future; Goals; Government; Growth and Development function; Health Personnel; Incidence; Industry; Inherited; Journals; Knowledge; Lead; Leiomyoma; Medicine; Modality; Molecular; Nurses; Participant; Patients; Peer Review; Physicians; Policies; Population; Publications; Quality of life; Research; Research Personnel; Schools; Symptoms; Therapeutic; Therapeutic Human Experimentation; Tissues; Translational Research; Universities; Uterine Fibroids; Woman; Work; base; burden of illness; catalyst; college; continuing medical education; design; editorial; genetic epidemiology; improved; inner city; innovation; multidisciplinary; outreach; patient advocacy group; posters; reproductive; research and development; symposium; web site

DESCRIPTION (provided by applicant): The focus of this tissue oriented conference is to answer pivotal questions regarding the higher incidence and characteristics of uterine leiomyomas in African American Women (AAW). The conference will feature scientific presentations that address the current state of knowledge and identify emerging issues regarding leiomyomas in the AAW and serve as a catalyst for discussion during the final session on "New Course for Future Research and Directions". Newer, promising and innovative research that will continue to build upon and enhance our understanding of the basic pathophysiology of uterine leiomyoma will be discussed. Innovations in treatment modalities with an emphasis on impact to the female reproductive tract, reproductive potential and quality of life will be presented. The target audience includes researchers working in the fields of biomedicine, epidemiology basic, clinical and translational science, therapeutics, academic medicine, government, industry; physicians, nurses, other healthcare workers and the lay community. All participants will be invited to present posters and special area will be assigned for poster presentation. The Conference proceedings will be edited by the editorial committee to prepare for publication in a peer reviewed journal and the entire contents will be posted on the Howard University Web Site. Accreditation Statement: The activity will be planned and implemented with essential areas and policies of the Accreditation Council for Continuing Medical Education through the Howard University College of Medicine Credit Designation Statement. Howard University College of Medicine will designate this educational activity for a maximum of 8 credits AMA Category 1 Credits. Physicians will only claim credit commensurate with the extent of their participation in the activity. .

描述(由申请者提供)：这次以组织为导向的会议的焦点是回答有关非裔美国女性子宫肌瘤的较高发病率和特征的关键问题。这次会议将以科学陈述为特色，阐述当前的知识状况，确定与AAW中的肌瘤有关的新问题，并作为最后一次会议期间关于“未来研究和方向的新课程”的讨论的催化剂。更新的，有希望的和创新的研究将继续建立在和加强我们对子宫肌瘤基本病理生理学的理解。将介绍治疗方式的创新，重点是对女性生殖道、生殖潜力和生活质量的影响。目标受众包括在生物医学、流行病学基础、临床和转化科学、治疗学、学术医学、政府和工业领域工作的研究人员；医生、护士、其他保健工作者和非专业人士。所有参赛者将被邀请展示海报，并将指定专区展示海报。会议议事录将由编辑委员会编辑，以准备在同行评议的期刊上发表，全部内容将刊登在霍华德大学的网站上。认证声明：活动将通过霍华德大学医学院学分指定声明，根据继续医学教育认证委员会的基本领域和政策来规划和实施。霍华德大学医学院将指定这项教育活动最多8个学分，AMA 1类学分。医生只会根据他们参与活动的程度来获得相应的积分。。